Aryavan Enterprise Ltd share price
You have to be logged in to add this to Watchlist.- ₹58.28(2.26%)February 13, 2026 15:42:23 PM IST
- NSE
- BSE
- Vol : 13.87 K (NSE + BSE)Last 20 day avg : 20.54 K
Aryavan Enterprise Ltd is trading 2.26% upper at Rs 58.28 as compared to its last closing price. Aryavan Enterprise Ltd has been trading in the price range of 63.33 & 54.75. Aryavan Enterprise Ltd has given 33.43% in this year & 12.36% in the last 5 days. The company posted a net profit of 0.52 Crores in its last quarter.Listed peers of Aryavan Enterprise Ltd include Sun Pharmaceutical Industries (-0.97%), Divi's Laboratories (-0.13%), Torrent Pharmaceuticals (-0.18%).The Mutual Fund holding in Aryavan Enterprise Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Aryavan Enterprise Ltd was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 14, 2026, 06:55 AM UTC
- BetaLow volatility-0.17Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Dividend YieldLower than industry0.88Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.08The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,698.00 | -0.97 | 4,07,849.42 | 35.56 | 5.66 | 0.97 | 0.50 |
| Divi's Laboratories | Neutral | 6,180.45 | -0.13 | 1,64,071.53 | 73.26 | 10.74 | 0.50 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,074.05 | -0.18 | 1,37,562.02 | 70.64 | 17.94 | 0.80 | 17.62 |
| Cipla | Bearish | 1,331.70 | 0.16 | 1,07,570.97 | 20.35 | 3.43 | 0.98 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,268.00 | -0.51 | 1,05,788.83 | 18.25 | 3.08 | 0.65 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2025-11-20 | Interim Dividend |
| 2025-11-14 | Quarterly Results |
| 2025-10-16 | Interim Dividend |
| 2025-08-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE360S01012
- BSE Code539455
- NSE Code
- Management Info
Aryavan Enterprise Ltd is trading at 58.28 as on Fri Feb 13 2026 10:12:23. This is 2.26% upper as compared to its previous closing price of 56.99.
The market capitalization of Aryavan Enterprise Ltd is 40.58 Cr as on Fri Feb 13 2026 10:12:23.
The 52 wk high for Aryavan Enterprise Ltd is 63.70 whereas the 52 wk low is 31.57
Aryavan Enterprise Ltd can be analyzed on the following key metrics -
- TTM P/E: 17.28
- Sector P/E: -
- Dividend Yield: 0.88%
- D/E ratio: 0.01
Aryavan Enterprise Ltd reported a net profit of 1.35 Cr in 2025.